NET PROFIT (x1000 EUR)
EMPLOYEES
Eurocine Vaccines AB
Closing information (x1000 EUR)
| Closing information | 2022/06 (consolidated) | 2021/06 (consolidated) | 2020/06 (consolidated) |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
1
|
30 |
| Earnings before taxes |
-1,887
|
-1,803
|
-880 |
| EBITDA |
-1,887
|
-1,802
|
-850 |
| Total assets |
1,760
|
3,532
|
3,096 |
| Current assets |
1,760
|
3,532
|
3,096 |
| Current liabilities |
301
|
380
|
223 |
| Equity capital |
1,459
|
3,152
|
2,873 |
| - share capital |
407
|
195
|
51 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2022/06 (consolidated) | 2021/06 (consolidated) | 2020/06 (consolidated) |
| Solvency |
82.9%
|
89.2%
|
92.8% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-107.2%
|
-51.0%
|
-27.5% |
| Current ratio |
584.7%
|
929.5%
|
1388.3% |
| Return on equity (ROE) |
-129.3%
|
-57.2%
|
-30.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2022/06 (consolidated) | 2021/06 (consolidated) | 2020/06 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.